​

Funding Round

Seed Round - BioSapien

Seed Round - BioSapien

Investment Firm

Overview

BioSapien is a biotech startup focusing on developing a 3D printed drug delivery platform to provide FDA approved drugs.

Announced Date

Nov 11, 2021

Funding Type

Seed

Highlights

Location

New York, New York, United States, North America

Social

Investor Lead

SOSV

SOSV

SOSV is a early_stage_venture and seed firm.

Participant Investors

9

Investor Name
Participant InvestorHikma Ventures
Participant InvestorSide Door Ventures
Participant InvestorInfinity Capital
Participant InvestorMicroVentures
Participant InvestorSOSV

Round Details and Background

BioSapien raised $1800000 on 2021-11-11 in Seed Round

BioSapien is a biotech startup focusing on developing a 3D printed drug delivery platform to provide FDA approved drugs.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 11, 2021
Grant - BioSapien
1-256.0K
Nov 01, 2022
Series A - BioSapien
3-35.0M
Jul 19, 2023
Convertible Note - BioSapien
1-undefined
Feb 21, 2024
Grant - BioSapien
1-undefined

Recent Activity

There is no recent news or activity for this profile.